GILD
Gilead Sciences Inc
Price:  
78.72 
USD
Volume:  
9,055,170.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead WACC - Weighted Average Cost of Capital

The WACC of Gilead Sciences Inc (GILD) is 7.7%.

The Cost of Equity of Gilead Sciences Inc (GILD) is 8.85%.
The Cost of Debt of Gilead Sciences Inc (GILD) is 4.30%.

Range Selected
Cost of equity 7.70% - 10.00% 8.85%
Tax rate 20.20% - 22.90% 21.55%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.8% - 8.7% 7.7%
WACC

Gilead WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.83 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 10.00%
Tax rate 20.20% 22.90%
Debt/Equity ratio 0.25 0.25
Cost of debt 4.00% 4.60%
After-tax WACC 6.8% 8.7%
Selected WACC 7.7%